|
DA-EPOCH Protocol Clinical Trials
1 actively recruiting trial across 1 location
Also known as: dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone
New Haven, Connecticut1 trial
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Yale Cancer Center, Clinical Trials Office
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.